Spinal stenosis prevalence to spur global interspinous spacer market: 5 observations

Written by Megan Wood | February 10, 2017 | Print  |

The global interspinous spacer market is expected to continue growing between 2016 and 2024, according to a Transparency Market Research report.

Here are five observations:

 

1. The growing number of spinal stenosis cases, as a result of aging, arthritis and heredity, will stimulate the market.

 

2. Surgeons often use interspinous spacers among the geriatric population.

 

3. In terms of end-users, orthopedic clinics lead the space, followed by hospitals and ambulatory surgery centers.

 

4. Developing countries will see market growth due to improvement in quality of life and more awareness about interspinous spacer products.

 

5. Dominant market players include:

 

• VertiFlex in San Clemente, Calif.
• Medyssey in Korea
• Zimmer Biomet in Warsaw, Ind.
• Depuy Synthes in Raynham, Mass.
• Precision Spine in Parsippany, N.J.
• Life Spine in Huntley, Ill.
• NuVasive in San Diego

 

More articles on devices:
92% of HF10 therapy trial patients report lowered back and leg pain — 5 things to know
Arlington Orthopedic Associates 1st in Texas to use NUsurface Meniscus Implant — 7 observations
Reston Hospital Center adds Mazor X to spinal surgery program — 4 notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months